1-Chlor-2-oxo-1-phenoxy-propan | 16473-26-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-Chlor-2-oxo-1-phenoxy-propan
• 英文别名: 1-Chloro-1-phenoxypropan-2-one
• CAS: 16473-26-0
• 化学式: C₉H₉ClO₂
• 分子量: 184.622
• InChiKey: RZJMYHJEJWMZAJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
  申请人：MILLENNIUM PHARMACEUTICALS, INC.

  公开号：EP1556047A2

  公开（公告）日：2005-07-27
• US5030644A
  申请人：——

  公开号：US5030644A

  公开（公告）日：1991-07-09
• [EN] RICIN INHIBITORS AND METHODS FOR USE THEREOF<br/>[FR] INHIBITEURS DE RICINE ET PROCEDES D'UTILISATION DE CES INHIBITEURS
  申请人：RES DEV FOUNDATION

  公开号：WO2001073438A1

  公开（公告）日：2001-10-04

  Ricin A-chain is an N-glycosidase that attacks ribosomal RNA at a highly conserved adenine residue. Crystallographic studies show that not only adenine and formycin, but also pterin-based rings can bind in the ricin active site. For a better understanding of the recognition mode between ricin, and adenine-like rings, the interaction energies and geometries were calculated for a number of complexes. Shiga toxin, a compound essentially identical to the protein originally isolated from Shigella dysenteriae, has an active protein chain that is a homologue of the ricin active chain, and catalyzes the same depurination reaction. The present invention is drawn to identifying inhibitors of ricin and Shiga toxin, using methods molecular mechanics and ab initio methods and using the identified inhibitors as antidotes to ricin or Shiga toxin, or to facilitate immunotoxin treatment by controlling non-specific cytotoxicity.
• [EN] PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES<br/>[FR] ANTAGONISTES VIS-A-VIS DU RECEPTEUR PGD2 POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES
  申请人：MILLENNIUM PHARM INC

  公开号：WO2004032848A2

  公开（公告）日：2004-04-22

  Disclosed herein are compounds represented by Structural Formula (I), wherein the variables are defined herein. Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 ('CRTH2') for the treatment of inflammatory disorders.